Secretive Moderna shared a new peek into its infectious disease vaccines efforts Thursday.

Marking a big step in its march toward potential approval, GlaxoSmithKline’s shingles vaccine candidate Shingrix won the support of an FDA panel.

A phase 3 study shows that Seqirus' MF59-adjuvanted quadrivalent flu vaccine provides better protection in those younger than two years old.

Here's other vaccine news of note for this week.

Nonprofit PATH secured a major commitment from the Gates Foundation for its new vaccine group.

Here's other vaccine news of note for this week.

Gavi's vaccine initiative will have saved 20 million lives and $350 billion in healthcare costs by 2020, a recent study found.

Following a rush of news coverage into an unregulated human trial of a herpes vaccine in St. Kitts, the island’s government is launching a probe.

Vaccines